Literature DB >> 2429858

Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies.

I Christensson-Nylander, M Herrera-Marschitz, W Staines, T Hökfelt, L Terenius, U Ungerstedt, C Cuello, W H Oertel, M Goldstein.   

Abstract

The effect of striatal ibotenic acid lesions on dynorphin-, substance P- and enkephalin-like immunoreactivities in the substantia nigra has been studied with immunohistochemistry as well as biochemistry. A comparison was made with the effects produced by intranigral ibotenic acid lesion and by 6-hydroxy-dopamine injection into the medial forebrain bundle. In addition, the effect of the striatal lesions on nigral glutamic acid decarboxylase (GAD)-positive structures was analysed with immunohistochemistry. The effect of the lesions was analysed functionally in the Ungerstedt rotational model, in order to obtain a preliminary evaluation of the extent of the lesions. The striatal lesions produced a parallel depletion of dynorphin and substance P levels in the substantia nigra, pars reticulata, ipsilateral to the treated side, which was dependent upon the extent and location of the lesion. Ibotenic acid lesions into the tail and the corpus of the striatum produced stronger nigral-peptide depletion than lesions in the head and the corpus of the striatum. Comparison of placement of lesions and localization of depleted area in the substantia nigra revealed a topographical relationship. Furthermore, the nigral depletion patterns of dynorphin and substance P were similar. The immunohistochemical analysis revealed that also GAD-positive fibers in the pars reticulata to a large extent disappeared after striatal lesions, in parallel to the dynorphin- and substance P-positive fibers. However, the depletion was less pronounced for GAD than for the peptides, probably related to presence of local GABA neurons in the zona reticulata of the substantia nigra. These results indicate that with the types of lesion used in this study it is not possible to provide evidence for a differential localization within the striatum of dynorphin-, substance P- and GABA-positive cell bodies projecting to the substantia nigra. The radioimmunoassay showed that (Leu)- but not (Met)-enkephalin was affected to the same extent as the dynorphin peptides, supporting the view that (Leu)-enkephalin in the pars reticulata of the substantia nigra is derived from proenkephalin B and not from proenkephalin A. In the immunohistochemical analysis (Met)-enkephalin-like immunoreactivity could only be detected in the pars compacta of the substantia nigra and did not seem to be affected by any of the lesions. The striatal lesions produced a behavioural asymmetry, which could be disclosed by stimulating the rats with apomorphine, which produced ipsilateral rotation.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2429858     DOI: 10.1007/bf00238213

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  116 in total

1.  Distribution of substance P-like immunoreactivity in the central nervous system of the rat--I. Cell bodies and nerve terminals.

Authors:  A Ljungdahl; T Hökfelt; G Nilsson
Journal:  Neuroscience       Date:  1978       Impact factor: 3.590

2.  Purification and characterization of tyrosine hydroxylase from a clonal pheochromocytoma cell line.

Authors:  K A Markey; H Kondo; L Shenkman; M Goldstein
Journal:  Mol Pharmacol       Date:  1980-01       Impact factor: 4.436

3.  A general procedure for analysis of proenkephalin B derived opioid peptides.

Authors:  I Christensson-Nylander; F Nyberg; U Ragnarsson; L Terenius
Journal:  Regul Pept       Date:  1985-05

4.  The distribution of immunoreactive alpha-neo-endorphin in the central nervous system of the rat.

Authors:  N Zamir; M Palkovits; M J Brownstein
Journal:  J Neurosci       Date:  1984-05       Impact factor: 6.167

5.  Atlas of the distribution of monoamine-containing nerve cell bodies in the brain stem of the cat.

Authors:  D Poitras; A Parent
Journal:  J Comp Neurol       Date:  1978-06-15       Impact factor: 3.215

6.  Diffuse enkephalin innervation from caudate to globus pallidus.

Authors:  F M Correa; R B Innis; L D Hester; S H Snyder
Journal:  Neurosci Lett       Date:  1981-08-07       Impact factor: 3.046

7.  Dynorphin peptides in human substantia nigra.

Authors:  I Christensson-Nylander; L Terenius
Journal:  Neuropeptides       Date:  1985-09       Impact factor: 3.286

8.  Neurotransmitters contained in the efferents of the striatum.

Authors:  W A Staines; J I Nagy; S R Vincent; H C Fibiger
Journal:  Brain Res       Date:  1980-08-04       Impact factor: 3.252

9.  Crossed connections of the substantia nigra in the rat.

Authors:  C R Gerfen; W A Staines; G W Arbuthnott; H C Fibiger
Journal:  J Comp Neurol       Date:  1982-05-20       Impact factor: 3.215

10.  The immunocytochemical localization of enkephalin in the central nervous system of the rat.

Authors:  J C Finley; J L Maderdrut; P Petrusz
Journal:  J Comp Neurol       Date:  1981-06-01       Impact factor: 3.215

View more
  27 in total

Review 1.  Organization and physiology of the substantia nigra.

Authors:  H Condé
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

2.  Two different types of dynorphin-A-immunoreactive terminals in rat substantia nigra.

Authors:  R Riesenberg; C Nitsch
Journal:  Cell Tissue Res       Date:  1990-07       Impact factor: 5.249

3.  GABAergic inputs from direct and indirect striatal projection neurons onto cholinergic interneurons in the primate putamen.

Authors:  Kalynda Kari Gonzales; Jean-Francois Pare; Thomas Wichmann; Yoland Smith
Journal:  J Comp Neurol       Date:  2013-08-01       Impact factor: 3.215

4.  Region specific regulation of glutamic acid decarboxylase mRNA expression by dopamine neurons in rat brain.

Authors:  N Lindefors; S Brene; M Herrera-Marschitz; H Persson
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

5.  Striato-nigral dynorphin and substance P pathways in the rat. II. Functional analysis.

Authors:  M Herrera-Marschitz; I Christensson-Nylander; T Sharp; W Staines; M Reid; T Hökfelt; L Terenius; U Ungerstedt
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

6.  Tachykinin antagonists inhibit the morphine withdrawal response in guinea-pigs.

Authors:  P A Johnston; L A Chahl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-03       Impact factor: 3.000

7.  Unilateral neonatal intracerebroventricular 6-hydroxydopamine administration in rats: I. Effects on spontaneous and drug-induced rotational behaviour and on postmortem monoamine levels.

Authors:  J Luthman; M Herrera-Marschitz; E Lindqvist
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

8.  Neuronal dependence of extracellular dopamine, acetylcholine, glutamate, aspartate and gamma-aminobutyric acid (GABA) measured simultaneously from rat neostriatum using in vivo microdialysis: reciprocal interactions.

Authors:  M Herrera-Marschitz; J J Meana; W T O'Connor; M Goiny; M S Reid; U Ungerstedt
Journal:  Amino Acids       Date:  1992-02       Impact factor: 3.520

9.  Damage of substantia nigra pars reticulata during pilocarpine-induced status epilepticus in the rat: immunohistochemical study of neurons, astrocytes and serum-protein extravasation.

Authors:  R Schmidt-Kastner; C Heim; K H Sontag
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

10.  Renal sensory and sympathetic nerves reinnervate the kidney in a similar time-dependent fashion after renal denervation in rats.

Authors:  Jan Mulder; Tomas Hökfelt; Mark M Knuepfer; Ulla C Kopp
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-02-13       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.